Antimicrobial and Antiproliferative Properties of 2‐Phenyl‐ N ‐(Pyridin‐2‐yl)acetamides
Chemical Biology & Drug Design · 2025
DOI: 10.1111/cbdd.70030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2025. Verfasst von Daria Nawrot und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic. Hauptthemen laut MEDLINE: Microbial Sensitivity Tests, Acetamides, Mycobacterium tuberculosis, Cell Proliferation. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Youth and Sports of the Czech Republic, Ministry of Health of the Czech Republic, Ministerstvo Zdravotnictví Ceské Republiky.
Abstract (Originalsprache)
Infectious diseases, including bacterial, fungal, and viral, have once again gained urgency in the drug development pipeline after the recent COVID‐19 pandemic. Tuberculosis (TB) is an old infectious disease for which eradication has not yet been successful. Novel agents are required to have potential activity against both drug‐sensitive and drug‐resistant strains of Mycobacterium tuberculosis ( Mtb ), the causative agent of TB. In this study, we present a series of 2‐phenyl‐ N ‐(pyridin‐2‐yl)acetamides in an attempt to investigate their possible antimycobacterial activity, cytotoxicity on the HepG2 liver cancer cell line, and—as complementary testing—their antibacterial and antifungal properties against a panel of clinically important pathogens. This screening resulted in one compound with promising antimycobacterial activity—compound 12 , MIC Mtb H37Ra = 15.625 μg/mL (56.26 μM). Compounds 17 , 24 , and 26 were further screened for their antiproliferative activity against human epithelial kidney cancer cell line A498, human prostate cancer cell line PC‐3, and human glioblastoma cell line U‐87MG, where they were found to possess interesting activity worth further exploration in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
- Biomedical Research Centre, University Hospital Hradec Kralove, Hradec Králové, Czech Republic.
- Department of Clinical Microbiology, University Hospital, Hradec Králové, Czech Republic.
ORCID-Profile: Daria Nawrot, Ondřej Janďourek, Klára Konečná, Martin Novák, Pavla Paterová, Pavel Bárta, Ghada Bouz, Jan Zitko, Martin Doležal
Förderung
- Ministry of Education, Youth and Sports of the Czech Republic
- Ministry of Health of the Czech Republic
- Ministerstvo Zdravotnictví Ceské Republiky
Zitieren
APA
Nawrot, D., Koutníková, B., Janďourek, O., Konečná, K., Novák, M., Paterová, P., Bárta, P., Bouz, G., Zitko, J., & Doležal, M. (2025). Antimicrobial and Antiproliferative Properties of 2‐Phenyl‐ N ‐(Pyridin‐2‐yl)acetamides. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70030
Vancouver
Nawrot D, Koutníková B, Janďourek O, Konečná K, Novák M, Paterová P, et al. Antimicrobial and Antiproliferative Properties of 2‐Phenyl‐ N ‐(Pyridin‐2‐yl)acetamides. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70030
BibTeX
@article{Nawrot2025,
author = {Nawrot, Daria and Koutníková, Barbora and Janďourek, Ondřej and Konečná, Klára and Novák, Martin and Paterová, Pavla and Bárta, Pavel and Bouz, Ghada and Zitko, Jan and Doležal, Martin},
title = {Antimicrobial and Antiproliferative Properties of 2‐Phenyl‐ N ‐(Pyridin‐2‐yl)acetamides},
journal = {Chemical Biology & Drug Design},
year = {2025},
doi = {10.1111/cbdd.70030}
}
EUVIMED